CVS Caremark (CVS) Tops Q1 EPS by 2c; Boosts FY12 adj.-EPS Outlook; Guides Q2
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $69.75 +1.50%
EPS Growth %: -22.3%
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -22.3%
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) reported Q1 EPS of $0.65, $0.02 better than the analyst estimate of $0.63. Revenue for the quarter came in at $30.8 million versus the consensus estimate of $30.31 billion.
Retail Pharmacy segment same stores sales increased 8.4%.
CVS Caremark sees FY2012 EPS of $3.23-$3.33, versus the consensus of $3.27.
CVS Caremark sees Q2 2012 EPS of $0.78-$0.80, versus the consensus of $0.74.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Retail Pharmacy segment same stores sales increased 8.4%.
CVS Caremark sees FY2012 EPS of $3.23-$3.33, versus the consensus of $3.27.
CVS Caremark sees Q2 2012 EPS of $0.78-$0.80, versus the consensus of $0.74.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Safe & Green (SGBX) Provides Update on Audit and Planned 10-K Filing
- Super Micro Computer (SMCI) now down nearly 20%
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
